BIOTECH TARGET N V - 19 Nov 2021 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role: 10%+ Owner
Signature: /s/ Daniel Koller
Issuer symbol: MGNX
Transactions as of: 19 Nov 2021
Net transactions value: +$3,700,320
Form type: 4
Filing time: 23 Nov 2021, 11:29:35 UTC
Previous filing: 01 Oct 2021
Next filing: 07 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MGNX	Common Stock	Purchase	$3,700,320	+200,000	+2.8%	$18.50	7,275,564	19 Nov 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Macrogenics, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.